KORU Medical Seeks FDA Clearance for Novel Drug Delivery System
ByAinvest
Tuesday, Dec 30, 2025 4:51 pm ET1min read
KRMD--
KORU Medical Systems, a company specializing in portable medical devices, is seeking FDA clearance for its drug delivery system. The company's focus is on subcutaneous drug delivery, particularly for patients with chronic illnesses such as primary immunodeficiency diseases and chronic inflammatory demyelinating polyneuropathy. The FREEDOM Infusion System, a mechanical infusion product, works to deliver life-saving therapies to patients through a low-pressure system that maintains a balance between patient tolerance and system delivery.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet